21K views · 213 reactions | Early trials of GLP-1 based drugs have shown promising results in patients with heart failure with preserved ejection fraction. A new study in JAMA uses real-world evidence that complements these trials.  https://ja.ma/3JGKybK #ESCCongress #WCCardio #ESC75Years | JAMA | Facebook

Heart failure with preserved ejection fraction (HFpEF) is a type of heart failure where the heart becomes stiff, and the heart walls thicken. This reduces the amount of blood available to be pumped around the body when the heart contracts, despite it contracting normally. This animation provides patients with the information they need to understand their condition and illustrates how using the online digital tool, My Medical Record can help manage the symptoms and treatment of HFpEF. | Sci Ani